Compare Edwards Lifesciences Corporation Common Stock (EW) vs HSBC Holdings plc (HSBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs HSBC Holdings plc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $83.82 (market cap $48.56B), while HSBC Holdings plc trades at $92.91 (market cap $311.92B). The key difference: HSBC Holdings plc is far larger — about 6.4× Edwards Lifesciences Corporation Common Stock's market cap, and HSBC Holdings plc pays a 4.05% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | HSBC | |
|---|---|---|
Market Cap | $48.56B | $311.92B |
Volume | 6,520,488 | 3,546,658 |
Sector | Health | Financials |
52-Week High | $95.18 | $107.86 |
52-Week Low | $72.65 | $65.67 |
Enterprise Value | $45.01B | $222.19B |
Typical Hold Time | — | 36 Days |
Dividend Yield | — | 4.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HSBC trades at $92.96, down 0.8% with bearish technical indicators. The bank shows strong profitability with 34.54% net margin and 12.44% ROE, while trading at reasonable valuations (P/E 13.23). Recent earnings show mixed results with Q2 beat but Q1 miss. Analyst sentiment is mixed with 38.1% buy ratings amid strategic expansions in US wealth management and Asian markets.
HSBC presents a balanced opportunity with solid fundamentals offset by near-term technical weakness. Growth initiatives in wealth management and Asian markets provide upside potential, while CFO transition and European restructuring pose execution risks. The stock's valuation remains attractive relative to earnings power.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →
